Philip A. Gorwood, France

Sainte-Anne Hospital CMME department
Professor Gorwood studied medicine from 1982-1988, and specialised in psychiatry in 1988. He is currently full Professor of Psychiatry at Sainte-Anne Hospital and Head of the CMME department [Clinique des Maladies Mentales et de L’Encéphale, with 60 beds], teaching at the Paris-Descartes University. He is also Head of one team research at INSERM (Institut National de la Santé et de la Recherche MEdical) research unit 1266 (Institute of Psychiatry and Neurosciences of Paris) devoted to genetic vulnerability of psychiatric and addictive disorders. Professor Gorwood has published over 300 scientific articles (h-index=45) and 24 book chapters. He has served on 16 editorial boards for journals in psychiatry, neuroscience and genetics, and was editor-in-chief of the journal European Psychiatry (IF=4.1), from 2005 to 2017. He is president (2019-2020) of the European Psychiatric Association (EPA). He joined the scientific advisory (SAB) board of the ECNP for addictive disorders in 2009. Philip Gorwood is the past-president of the national associations on alcoholism (FRA) and eating disorders (AFDAS-TCA). In 1992, Professor Gorwood received the Lilly ‘First Communication’ award and later in 1997, the French Association for Biological Psychiatry ‘Best Communication of the Year’ award. In 1999, he received the Association of European Psychiatry ‘Young Researcher’ award; in 2000 the French National Academy of Medicine for the best research on addiction, and in 2016 the FONDAMENTAL award as the best researcher of the year in psychiatry. Key publications: Gorwood P et al. Br J Psychiatry, 1992, 161 : 55-58 and 2010; 196:139-142. Gorwood P et al American Journal of Psychiatry 1995; 152: 208-212, 1996; 153: 1173-1177 and 2008; 165:731-739, Gorwood P et al. Biological psychiatry 2000; 48(4): 259-264 and 2003; 53: 85-92; Gorwood P et al. Molecular Psychiatry 2002; 7: 90-94, Gorwood P et al. Human Genetics, 2012, 131(6):803-22. Millan et al., 2012, Nature Reviews Drug Discovery, 11(2):141-68.

Presenter of 8 Presentations

European 09:00 - 09:10

Welcome and introduction by EPA and GAMIAN-Europe

European 12:25 - 12:35
Mental Health Policy 15:00 - 15:00

Key Priorities for Mental Health Policies Beyond 2020: EPA contribution - ECP002

ALL SESSIONS
Mental Health Policy
Clinical/Therapeutic 10:00 - 10:00

When Does it Stop? Defining Remission and Recovery in Eating Disorders - S163

ALL SESSIONS
Clinical/Therapeutic

Abstract

Abstract Body

Eating disorders concern around 5% of the general population (APA, 2000) and are explained by a constellation of risk factors including genetic, biological, psychological and social factors (Guy-Rubin & Gorwood, 2016). Anorexia nervosa, for example, has the highest mortality rate of psychiatric disorders (Arcelus et al., 2011), either by suicide or somatic complications, with an average of 1% of death every year. The aim of any care provided to patients with anorexia nervosa relies on normal BMI, and especially for hospitalization, as its length is usually fixing a healthy weight compatible with discharge (Lund et al., 2009). Nevertheless, one patient out of two relapses in the year following hospitalization (Eckert et al., 1995; Steinhausen et al., 2008) and suicidal mortality increases with the length of follow up (Steinhausen et al., 2002). There is therefore an unmet need to use more accurate cues for treatment aims, more specifically targeting causes (the involved abnormal mechanisms) than consequences (abnormal weight), potentially providing more reliable criteria for remission and recovery.

Consensus for remission and recovery in eating disorders are also important to detect between differencies of outcome between countries, disorders and clinicans.

Anotehr aspect which is lacking, while defining what is remission in eating disorders, concerns quality of life, level of functioning, and wellbeingness. These concepts might be more complex and heterogeneous, but they capture important aspects of improvement, as "patient centered" rather than "disorder centered".

We will expose the already proposed definitions of remisison and recovery (Khalsa et al. Journal of Eating Disorders (2017) 5:20) and will discuss the pros and cons of homogeneous criteria for eating disorders

Hide
European 16:00 - 16:15

Policy Considerations From Professional Perspective. 2 - W096

ALL SESSIONS
European